Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Medpace Holdings Inc. (MEDP)

89.94   -5.19 (-5.46%) 02-28 16:00
Open: 92 Pre. Close: 95.13
High: 95.12 Low: 88.1
Volume: 523,144 Market Cap: 3246M
Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 95.225 - 96 96 - 96.521
Low: 86.573 - 87.385 87.385 - 87.93
Close: 88.863 - 90.137 90.137 - 90.992

Technical analysis

as of: 2020-02-28 4:30:28 PM
Stoxline posted a STRONG SELL today, same as yesterday. Downward movement continues.
Target: Six months: 115.73     One year: 127.42
Support: Support1: 82.89    Support2: 68.96
Resistance: Resistance1: 99.08    Resistance2: 109.09
Pivot: 97.40
Moving Average: MA(5): 97.30     MA(20): 95.87
MA(100): 82.90     MA(250): 72.52
MACD: MACD(12,26): 2.14     Signal(9): 3.04
Stochastic oscillator: %K(14,3): 29.34     %D(3): 48.87
RSI: RSI(14): 40.61
52-week: High: 109.09  Low: 50.14  Change(%): 63.6
Average Vol(K): 3-Month: 22171  10-Days: 36225

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
MEDP has closed below the lower band by 10.1%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 35.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2019 Results
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the fourth quarter and full year ended December 31, 2019. Fourth Quarter and Full Year 2019 Financial Results Revenue for the three months ended December 31, 2019 increased 19.7% to $229.9 million, compared to $192.1 million for the comparable prior-year period. Revenue for the year ended December 31, 2019 increased 22.2% to $861.0 million, compared to $704.6 million for the year

The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs on Feb. 20.) Akebia Therapeutics Inc (NASDAQ: AKBA ) Aptose Biosciences Inc (NASDAQ: APTO ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) Arcus Biosciences Inc (NYSE: RCUS ) BELLUS Health Inc (NASDAQ: BLU ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Calithera Biosciences Inc (NASDAQ: CALA ) Cue Biopharma Inc (NASDAQ: CUE ) DexCom, Inc. (NASDAQ: DXCM ) Fate Therapeutics Inc (NASDAQ: FATE ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Grifols SA - ADR ADR Class B (NASDAQ: GRFS ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Masimo Corporation (NASDAQ: MASI ) (announced its fourth-quarter results) Medpace Holdings Inc (NASDAQ: MEDP ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Relmada Therapeutics Inc (NASDAQ: RLMD ) Repro-Med Systems, Inc. (NASDAQ: KRMD ) Revance Therapeutics Inc (NASDAQ: RVNC ) (announced $287.5-million debt offering) Revolution Medicines Inc (NASDAQ: RVMD ) (went public Feb. 13) Scpharmaceuticals Inc (NASDAQ: SCPH ) Soligenix, Inc.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Diagnostics Research
Shares Out. (M) 36.03
Shares Float (M) 27.36
% Held by Insiders 23.44
% Held by Institutions 80.51
Shares Short (K) 2380
Shares Short P. Month (K)

Stock Financials

EPS 2.490
Book Value (p.s.) 19.320
PEG Ratio 2.92
Profit Margin 11.35
Operating Margin 14.80
Return on Assets (ttm) 7.5
Return on Equity (ttm) 14.9
Qtrly Rev. Growth 20.6
Gross Profit (p.s.) 12.554
Sales Per Share
EBITDA (p.s.) 4.147
Qtrly Earnings Growth 24.20
Operating Cash Flow (M) 184.37
Levered Free Cash Flow (M) 140.92

Stock Valuations

P/E 36.12
P/E Growth Ratio -0.05
P/BV 4.66
P/S 3.90
P/CF 17.58

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.